XNCR Q1 2020 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32M-71.1% YoY

Gross Profit

-$2M-4.8% margin

Operating Income

-$9M-27.1% margin

Net Income

-$8M-24.9% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+821.1%

Cash Flow

Operating Cash Flow

$9M

Free Cash Flow

$7M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$667M

Total Liabilities

$74M

Stockholders' Equity

$593M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$112M	-71.1%
Gross Profit	-$2M	$84M	-101.9%
Operating Income	-$9M	$78M	-111.2%
Net Income	-$8M	$80M	-110.1%

Revenue Segments

License

$16M48%

Milestone

$13M39%

Royalty

$3M10%

Collaboration

$1M3%